Leaflet EPIRAX 5mg / 2.5mg sugar-coated tablets

Product code:
W44062001
Quantity:
30
Indicated for:
gastrointestinal spasms; functional abdominal pain
Route of administration:
oral
Substance:
chlordiazepoxide + clidinium bromide (analgesics and antipyretics)
ATC
A03CA02 — Alimentary tract and metabolism | Antispasmodics in combination with psycholeptics | Synthetic anticholinergic agents in combination with psycholeptics
Chlordiazepoxide and clidinium bromide are used together to treat gastrointestinal disorders associated with anxiety, such as irritable bowel syndrome. Chlordiazepoxide is a benzodiazepine that reduces anxiety, while clidinium bromide is an anticholinergic that helps relax the smooth muscles of the gastrointestinal tract.

This combination is taken orally, usually in capsule form, and should be used as directed by your doctor. It is important not to exceed the prescribed dose to avoid adverse effects.

Side effects may include drowsiness, dizziness, dry mouth, or constipation. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as glaucoma or prostate enlargement, as these may affect the safety of this combination.

General data about EPIRAX 5mg / 2.5mg

Substance:
chlordiazepoxide + clidinium bromide
Date of latest medicines list:
01-07-2020
Product code:
W44062001
Concentration:
5mg / 2.5mg
Pharmaceutical form:
sugar-coated tablets
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.